Dignitana AB (publ) (DIGN.ST)
SEK 1.97
(3.42%)
SEK 1.97
(3.42%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 13.07 Million SEK | 39.15% |
| 2022 | 9.39 Million SEK | 3.4% |
| 2021 | 9.08 Million SEK | 113.15% |
| 2020 | -69.14 Million SEK | -475.7% |
| 2019 | -12.01 Million SEK | -0.31% |
| 2018 | -11.97 Million SEK | -180.58% |
| 2017 | 14.85 Million SEK | 145.21% |
| 2016 | -32.86 Million SEK | -72.59% |
| 2015 | -19.04 Million SEK | -1640.59% |
| 2014 | -1.09 Million SEK | 90.0% |
| 2013 | -10.93 Million SEK | 33.64% |
| 2012 | -16.48 Million SEK | -1644.34% |
| 2011 | -945 Thousand SEK | 92.61% |
| 2010 | -12.78 Million SEK | -1595.62% |
| 2009 | -754 Thousand SEK | 19.79% |
| 2008 | -940 Thousand SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 8.37 Million SEK | -35.97% |
| 2024 Q2 | 8.26 Million SEK | -1.25% |
| 2023 Q1 | -2.03 Million SEK | -121.6% |
| 2023 Q3 | 4.76 Million SEK | -21.76% |
| 2023 FY | 13.07 Million SEK | 39.15% |
| 2023 Q4 | 13.07 Million SEK | 174.32% |
| 2023 Q2 | 6.09 Million SEK | 400.15% |
| 2022 Q2 | 1.79 Million SEK | -83.93% |
| 2022 FY | 9.39 Million SEK | 3.4% |
| 2022 Q4 | 9.39 Million SEK | 179.7% |
| 2022 Q1 | 11.15 Million SEK | 22.75% |
| 2022 Q3 | 3.36 Million SEK | 87.4% |
| 2021 Q3 | -16.33 Million SEK | 48.72% |
| 2021 FY | 9.08 Million SEK | 113.15% |
| 2021 Q1 | -36.87 Million SEK | 46.67% |
| 2021 Q2 | -31.86 Million SEK | 13.6% |
| 2021 Q4 | 9.08 Million SEK | 155.63% |
| 2020 Q3 | -5.31 Million SEK | -268.92% |
| 2020 Q4 | -69.14 Million SEK | -1201.99% |
| 2020 Q2 | 3.14 Million SEK | 507.01% |
| 2020 Q1 | 517.91 Thousand SEK | 104.31% |
| 2020 FY | -69.14 Million SEK | -475.7% |
| 2019 Q3 | -29.9 Million SEK | -484.91% |
| 2019 FY | -12.01 Million SEK | -0.31% |
| 2019 Q1 | -12.35 Million SEK | -3.15% |
| 2019 Q2 | -5.11 Million SEK | 58.6% |
| 2019 Q4 | -12.01 Million SEK | 59.84% |
| 2018 Q4 | -11.97 Million SEK | -378.65% |
| 2018 FY | -11.97 Million SEK | -180.58% |
| 2018 Q3 | 4.29 Million SEK | 174.74% |
| 2018 Q2 | -5.74 Million SEK | 66.5% |
| 2018 Q1 | -17.16 Million SEK | -215.49% |
| 2017 Q3 | 5.23 Million SEK | 202.28% |
| 2017 Q2 | -5.12 Million SEK | 71.54% |
| 2017 Q1 | -17.99 Million SEK | 45.25% |
| 2017 FY | 14.85 Million SEK | 145.21% |
| 2017 Q4 | 14.85 Million SEK | 183.69% |
| 2016 FY | -32.86 Million SEK | -72.59% |
| 2016 Q3 | -42.34 Million SEK | 17.85% |
| 2016 Q4 | -32.86 Million SEK | 22.38% |
| 2016 Q2 | -51.54 Million SEK | -356.41% |
| 2016 Q1 | -11.29 Million SEK | 40.7% |
| 2015 Q2 | -6.93 Million SEK | 34.51% |
| 2015 FY | -19.04 Million SEK | -1640.59% |
| 2015 Q4 | -19.04 Million SEK | 35.96% |
| 2015 Q3 | -29.73 Million SEK | -328.59% |
| 2015 Q1 | -10.59 Million SEK | -868.35% |
| 2014 Q1 | -4.56 Million SEK | 58.3% |
| 2014 FY | -1.09 Million SEK | 90.0% |
| 2014 Q2 | -865.36 Thousand SEK | 81.03% |
| 2014 Q4 | -1.09 Million SEK | 72.12% |
| 2014 Q3 | -3.92 Million SEK | -353.5% |
| 2013 Q3 | -8.96 Million SEK | -81.71% |
| 2013 Q2 | -4.93 Million SEK | 57.07% |
| 2013 FY | -10.93 Million SEK | 33.64% |
| 2013 Q4 | -10.93 Million SEK | -22.06% |
| 2013 Q1 | -11.48 Million SEK | 30.3% |
| 2012 Q3 | -752.46 Thousand SEK | 28.18% |
| 2012 Q1 | - SEK | 100.0% |
| 2012 Q2 | -1.04 Million SEK | 0.0% |
| 2012 Q4 | -16.48 Million SEK | -2090.66% |
| 2012 FY | -16.48 Million SEK | -1644.34% |
| 2011 Q3 | -2.14 Million SEK | 78.6% |
| 2011 Q4 | -945 Thousand SEK | 55.86% |
| 2011 Q2 | -10 Million SEK | -154.53% |
| 2011 FY | -945 Thousand SEK | 92.61% |
| 2011 Q1 | -3.93 Million SEK | 69.25% |
| 2010 Q4 | -12.78 Million SEK | -399.05% |
| 2010 Q3 | 4.27 Million SEK | 135.7% |
| 2010 FY | -12.78 Million SEK | -1595.62% |
| 2010 Q1 | 1.26 Million SEK | -53.9% |
| 2010 Q2 | 1.81 Million SEK | 43.28% |
| 2009 Q3 | 1.71 Million SEK | 641.65% |
| 2009 FY | -754 Thousand SEK | 19.79% |
| 2009 Q2 | -316.33 Thousand SEK | 0.0% |
| 2009 Q4 | 2.74 Million SEK | 60.27% |
| 2008 FY | -940 Thousand SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acarix AB (publ) | -35.14 Million SEK | 137.204% |
| ADDvise Group AB (publ) | 1.22 Billion SEK | 98.934% |
| ADDvise Group AB (publ) | 1.22 Billion SEK | 98.934% |
| Arcoma AB | -1.12 Million SEK | 1259.309% |
| Bactiguard Holding AB (publ) | 109.88 Million SEK | 88.099% |
| BICO Group AB (publ) | 927.9 Million SEK | 98.591% |
| Boule Diagnostics AB (publ) | 128.8 Million SEK | 89.847% |
| CellaVision AB (publ) | -56.94 Million SEK | 122.965% |
| Clinical Laserthermia Systems AB (publ) | -14.87 Million SEK | 187.901% |
| Chordate Medical Holding AB (publ) | -8.45 Million SEK | 254.662% |
| C-Rad AB (publ) | -127.6 Million SEK | 110.248% |
| Duearity AB (publ) | 10.23 Million SEK | -27.817% |
| Episurf Medical AB (publ) | -52.7 Million SEK | 124.814% |
| Getinge AB (publ) | 5.4 Billion SEK | 99.758% |
| Scandinavian Real Heart AB (Publ) | -35.05 Million SEK | 137.306% |
| Iconovo AB (publ) | -10.75 Million SEK | 221.586% |
| Integrum AB (publ) | -10.47 Million SEK | 224.822% |
| Luxbright AB (publ) | -13.83 Million SEK | 194.532% |
| Mentice AB (publ) | -49.56 Million SEK | 126.384% |
| OssDsign AB (publ) | -162.78 Million SEK | 108.033% |
| Paxman AB (publ) | -11.41 Million SEK | 214.6% |
| Promimic AB (publ) | -50.32 Million SEK | 125.986% |
| Qlife Holding AB (publ) | 19.07 Million SEK | 31.426% |
| SciBase Holding AB (publ) | -27.32 Million SEK | 147.859% |
| ScandiDos AB (publ) | -1.53 Million SEK | 954.148% |
| Sectra AB (publ) | -772.85 Million SEK | 101.692% |
| Sedana Medical AB (publ) | -226.87 Million SEK | 105.764% |
| Senzime AB (publ) | -139.54 Million SEK | 109.371% |
| SpectraCure AB (publ) | -50.23 Million SEK | 126.032% |
| Stille AB | -178.5 Million SEK | 107.326% |
| Vitrolife AB (publ) | 1.22 Billion SEK | 98.935% |
| Xvivo Perfusion AB (publ) | -214.65 Million SEK | 106.092% |